ASCO 2023: Oncolytic Viruses Post-Conference Report

With over 5000 abstracts presented at ASCO 2023, the Beacon team have been dedicated to narrowing down the relevant abstracts vital for your research endeavors. We have identified 41 oncolytic viruses-relevant abstracts including 37 clinical and 4 preclinical . This is a 31% increase in the number of oncolytic viruses-relevant abstracts presented in 2022. Download the post-conference below to view the abstract analysis and summary.

ASCO 2023: Oncolytic Viruses Abstract Highlights

This post-conference report offers a complete guide to all the oncolytic viruses topics and provides you with an abstract analysis split into data type, viral family, and clinical abstract properties. Also the clinical, trial outline, and preclinical abstract summaries.

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search